Novartis AG
Novartis AG NVSEF Peers
See (NVSEF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NVSEF | $110.25 | -1.82% | 209.2B | 17.28 | $6.38 | +3.59% |
| RHHBY | $40.41 | +2.24% | 257.9B | 25.90 | $1.56 | +3.38% |
| RHHVF | $317.00 | -1.22% | 255.9B | 25.46 | $12.45 | +3.47% |
| RHHBF | $337.00 | +0.25% | 255.6B | 26.79 | $12.58 | +3.27% |
| AZNCF | $143.20 | +0.07% | 222.1B | 28.81 | $4.97 | +2.17% |
| SNYNF | $99.97 | -4.06% | 121.8B | 17.51 | $5.71 | +4.38% |
| BMYMP | $790.00 | N/A | 95.6B | 3511.11 | $0.23 | +0.13% |
| CHGCF | $52.29 | -3.91% | 86B | 29.88 | $1.75 | +0.01% |
| CHGCY | $26.11 | +0.02% | 85.9B | 30.01 | $0.87 | +0.93% |
| GLAXF | $19.92 | +6.44% | 80.7B | 20.12 | $0.99 | +4.01% |
Stock Comparison
NVSEF vs RHHBY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, RHHBY has a market cap of 257.9B. Regarding current trading prices, NVSEF is priced at $110.25, while RHHBY trades at $40.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas RHHBY's P/E ratio is 25.90. In terms of profitability, NVSEF's ROE is +0.31%, compared to RHHBY's ROE of +0.35%. Regarding short-term risk, NVSEF is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs RHHVF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, RHHVF has a market cap of 255.9B. Regarding current trading prices, NVSEF is priced at $110.25, while RHHVF trades at $317.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas RHHVF's P/E ratio is 25.46. In terms of profitability, NVSEF's ROE is +0.31%, compared to RHHVF's ROE of +0.35%. Regarding short-term risk, NVSEF is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs RHHBF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, RHHBF has a market cap of 255.6B. Regarding current trading prices, NVSEF is priced at $110.25, while RHHBF trades at $337.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas RHHBF's P/E ratio is 26.79. In terms of profitability, NVSEF's ROE is +0.31%, compared to RHHBF's ROE of +0.35%. Regarding short-term risk, NVSEF is more volatile compared to RHHBF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs AZNCF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, AZNCF has a market cap of 222.1B. Regarding current trading prices, NVSEF is priced at $110.25, while AZNCF trades at $143.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas AZNCF's P/E ratio is 28.81. In terms of profitability, NVSEF's ROE is +0.31%, compared to AZNCF's ROE of +0.19%. Regarding short-term risk, NVSEF is more volatile compared to AZNCF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs SNYNF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, SNYNF has a market cap of 121.8B. Regarding current trading prices, NVSEF is priced at $110.25, while SNYNF trades at $99.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas SNYNF's P/E ratio is 17.51. In terms of profitability, NVSEF's ROE is +0.31%, compared to SNYNF's ROE of +0.10%. Regarding short-term risk, NVSEF is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs BMYMP Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, BMYMP has a market cap of 95.6B. Regarding current trading prices, NVSEF is priced at $110.25, while BMYMP trades at $790.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas BMYMP's P/E ratio is 3511.11. In terms of profitability, NVSEF's ROE is +0.31%, compared to BMYMP's ROE of +0.32%. Regarding short-term risk, NVSEF is more volatile compared to BMYMP. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs CHGCF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, CHGCF has a market cap of 86B. Regarding current trading prices, NVSEF is priced at $110.25, while CHGCF trades at $52.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas CHGCF's P/E ratio is 29.88. In terms of profitability, NVSEF's ROE is +0.31%, compared to CHGCF's ROE of +0.17%. Regarding short-term risk, NVSEF is more volatile compared to CHGCF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs CHGCY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, CHGCY has a market cap of 85.9B. Regarding current trading prices, NVSEF is priced at $110.25, while CHGCY trades at $26.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas CHGCY's P/E ratio is 30.01. In terms of profitability, NVSEF's ROE is +0.31%, compared to CHGCY's ROE of +0.17%. Regarding short-term risk, NVSEF is less volatile compared to CHGCY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs GLAXF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, GLAXF has a market cap of 80.7B. Regarding current trading prices, NVSEF is priced at $110.25, while GLAXF trades at $19.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas GLAXF's P/E ratio is 20.12. In terms of profitability, NVSEF's ROE is +0.31%, compared to GLAXF's ROE of +0.22%. Regarding short-term risk, NVSEF is less volatile compared to GLAXF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs DSKYF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, DSKYF has a market cap of 50.4B. Regarding current trading prices, NVSEF is priced at $110.25, while DSKYF trades at $26.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas DSKYF's P/E ratio is 24.76. In terms of profitability, NVSEF's ROE is +0.31%, compared to DSKYF's ROE of +0.11%. Regarding short-term risk, NVSEF is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs DSNKY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, DSNKY has a market cap of 49.8B. Regarding current trading prices, NVSEF is priced at $110.25, while DSNKY trades at $26.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas DSNKY's P/E ratio is 24.49. In terms of profitability, NVSEF's ROE is +0.31%, compared to DSNKY's ROE of +0.15%. Regarding short-term risk, NVSEF is more volatile compared to DSNKY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs BAYRY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, BAYRY has a market cap of 27.7B. Regarding current trading prices, NVSEF is priced at $110.25, while BAYRY trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas BAYRY's P/E ratio is -7.43. In terms of profitability, NVSEF's ROE is +0.31%, compared to BAYRY's ROE of -0.08%. Regarding short-term risk, NVSEF is more volatile compared to BAYRY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs OTSKY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, OTSKY has a market cap of 26.8B. Regarding current trading prices, NVSEF is priced at $110.25, while OTSKY trades at $25.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas OTSKY's P/E ratio is 11.08. In terms of profitability, NVSEF's ROE is +0.31%, compared to OTSKY's ROE of +0.03%. Regarding short-term risk, NVSEF is less volatile compared to OTSKY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs OTSKF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, OTSKF has a market cap of 24.9B. Regarding current trading prices, NVSEF is priced at $110.25, while OTSKF trades at $47.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas OTSKF's P/E ratio is 10.51. In terms of profitability, NVSEF's ROE is +0.31%, compared to OTSKF's ROE of +0.03%. Regarding short-term risk, NVSEF is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs ORINY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, ORINY has a market cap of 17.7B. Regarding current trading prices, NVSEF is priced at $110.25, while ORINY trades at $32.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas ORINY's P/E ratio is 23.18. In terms of profitability, NVSEF's ROE is +0.31%, compared to ORINY's ROE of +0.37%. Regarding short-term risk, NVSEF is less volatile compared to ORINY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs ALPMY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, ALPMY has a market cap of 17.6B. Regarding current trading prices, NVSEF is priced at $110.25, while ALPMY trades at $9.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas ALPMY's P/E ratio is 49.05. In terms of profitability, NVSEF's ROE is +0.31%, compared to ALPMY's ROE of +0.01%. Regarding short-term risk, NVSEF is less volatile compared to ALPMY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs ALPMF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, ALPMF has a market cap of 16.8B. Regarding current trading prices, NVSEF is priced at $110.25, while ALPMF trades at $9.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas ALPMF's P/E ratio is 46.79. In terms of profitability, NVSEF's ROE is +0.31%, compared to ALPMF's ROE of +0.01%. Regarding short-term risk, NVSEF is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs GIKLY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, GIKLY has a market cap of 13.7B. Regarding current trading prices, NVSEF is priced at $110.25, while GIKLY trades at $5.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas GIKLY's P/E ratio is 39.62. In terms of profitability, NVSEF's ROE is +0.31%, compared to GIKLY's ROE of +0.03%. Regarding short-term risk, NVSEF is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs CSPCY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, CSPCY has a market cap of 12.1B. Regarding current trading prices, NVSEF is priced at $110.25, while CSPCY trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas CSPCY's P/E ratio is 20.25. In terms of profitability, NVSEF's ROE is +0.31%, compared to CSPCY's ROE of +0.18%. Regarding short-term risk, NVSEF is more volatile compared to CSPCY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs RCDTF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, RCDTF has a market cap of 10.1B. Regarding current trading prices, NVSEF is priced at $110.25, while RCDTF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas RCDTF's P/E ratio is 21.49. In terms of profitability, NVSEF's ROE is +0.31%, compared to RCDTF's ROE of +0.22%. Regarding short-term risk, NVSEF is more volatile compared to RCDTF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs KYKOF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, KYKOF has a market cap of 8.3B. Regarding current trading prices, NVSEF is priced at $110.25, while KYKOF trades at $15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas KYKOF's P/E ratio is 23.24. In terms of profitability, NVSEF's ROE is +0.31%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, NVSEF is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs HAWPY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, HAWPY has a market cap of 8B. Regarding current trading prices, NVSEF is priced at $110.25, while HAWPY trades at $35.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas HAWPY's P/E ratio is 17.89. In terms of profitability, NVSEF's ROE is +0.31%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, NVSEF is less volatile compared to HAWPY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs CHJTF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, CHJTF has a market cap of 7.1B. Regarding current trading prices, NVSEF is priced at $110.25, while CHJTF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas CHJTF's P/E ratio is 12.40. In terms of profitability, NVSEF's ROE is +0.31%, compared to CHJTF's ROE of +0.18%. Regarding short-term risk, NVSEF is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs GIFOF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, GIFOF has a market cap of 6.7B. Regarding current trading prices, NVSEF is priced at $110.25, while GIFOF trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas GIFOF's P/E ratio is 31.73. In terms of profitability, NVSEF's ROE is +0.31%, compared to GIFOF's ROE of +0.03%. Regarding short-term risk, NVSEF is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs ORINF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, ORINF has a market cap of 6B. Regarding current trading prices, NVSEF is priced at $110.25, while ORINF trades at $43.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas ORINF's P/E ratio is 17.42. In terms of profitability, NVSEF's ROE is +0.31%, compared to ORINF's ROE of +0.37%. Regarding short-term risk, NVSEF is less volatile compared to ORINF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs GIFLF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, GIFLF has a market cap of 5.9B. Regarding current trading prices, NVSEF is priced at $110.25, while GIFLF trades at $9.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas GIFLF's P/E ratio is 36.65. In terms of profitability, NVSEF's ROE is +0.31%, compared to GIFLF's ROE of +0.03%. Regarding short-term risk, NVSEF is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs DPHAY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, NVSEF is priced at $110.25, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, NVSEF's ROE is +0.31%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, NVSEF is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs OPHLY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, OPHLY has a market cap of 5B. Regarding current trading prices, NVSEF is priced at $110.25, while OPHLY trades at $3.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas OPHLY's P/E ratio is 14.28. In terms of profitability, NVSEF's ROE is +0.31%, compared to OPHLY's ROE of +0.10%. Regarding short-term risk, NVSEF is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs OPHLF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, OPHLF has a market cap of 4.8B. Regarding current trading prices, NVSEF is priced at $110.25, while OPHLF trades at $10.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas OPHLF's P/E ratio is 13.74. In terms of profitability, NVSEF's ROE is +0.31%, compared to OPHLF's ROE of +0.10%. Regarding short-term risk, NVSEF is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs SNPHF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, SNPHF has a market cap of 4.3B. Regarding current trading prices, NVSEF is priced at $110.25, while SNPHF trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas SNPHF's P/E ratio is 17.56. In terms of profitability, NVSEF's ROE is +0.31%, compared to SNPHF's ROE of +0.06%. Regarding short-term risk, NVSEF is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs SNPHY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, SNPHY has a market cap of 3.6B. Regarding current trading prices, NVSEF is priced at $110.25, while SNPHY trades at $10.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas SNPHY's P/E ratio is 14.41. In terms of profitability, NVSEF's ROE is +0.31%, compared to SNPHY's ROE of +0.06%. Regarding short-term risk, NVSEF is less volatile compared to SNPHY. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs PTKFF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, PTKFF has a market cap of 3.4B. Regarding current trading prices, NVSEF is priced at $110.25, while PTKFF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas PTKFF's P/E ratio is N/A. In terms of profitability, NVSEF's ROE is +0.31%, compared to PTKFF's ROE of +0.15%. Regarding short-term risk, NVSEF is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs VRBCF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, VRBCF has a market cap of 2.7B. Regarding current trading prices, NVSEF is priced at $110.25, while VRBCF trades at $324.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas VRBCF's P/E ratio is 16.40. In terms of profitability, NVSEF's ROE is +0.31%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, NVSEF is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs HAWPF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, HAWPF has a market cap of 2.2B. Regarding current trading prices, NVSEF is priced at $110.25, while HAWPF trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas HAWPF's P/E ratio is 12.50. In terms of profitability, NVSEF's ROE is +0.31%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, NVSEF is more volatile compared to HAWPF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs LYPHF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, LYPHF has a market cap of 960M. Regarding current trading prices, NVSEF is priced at $110.25, while LYPHF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas LYPHF's P/E ratio is 12.76. In terms of profitability, NVSEF's ROE is +0.31%, compared to LYPHF's ROE of +0.06%. Regarding short-term risk, NVSEF is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs CMOPF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, CMOPF has a market cap of 880.8M. Regarding current trading prices, NVSEF is priced at $110.25, while CMOPF trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas CMOPF's P/E ratio is 5.98. In terms of profitability, NVSEF's ROE is +0.31%, compared to CMOPF's ROE of +0.14%. Regarding short-term risk, NVSEF is less volatile compared to CMOPF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs TGRNF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, TGRNF has a market cap of 851.7M. Regarding current trading prices, NVSEF is priced at $110.25, while TGRNF trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas TGRNF's P/E ratio is 11.08. In terms of profitability, NVSEF's ROE is +0.31%, compared to TGRNF's ROE of +0.09%. Regarding short-term risk, NVSEF is less volatile compared to TGRNF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs JCRRF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, JCRRF has a market cap of 636M. Regarding current trading prices, NVSEF is priced at $110.25, while JCRRF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas JCRRF's P/E ratio is -261.00. In terms of profitability, NVSEF's ROE is +0.31%, compared to JCRRF's ROE of -0.01%. Regarding short-term risk, NVSEF is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs MAYNF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, MAYNF has a market cap of 307.9M. Regarding current trading prices, NVSEF is priced at $110.25, while MAYNF trades at $3.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas MAYNF's P/E ratio is -3.79. In terms of profitability, NVSEF's ROE is +0.31%, compared to MAYNF's ROE of -0.35%. Regarding short-term risk, NVSEF is less volatile compared to MAYNF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs PTKFY Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, PTKFY has a market cap of 20.5M. Regarding current trading prices, NVSEF is priced at $110.25, while PTKFY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas PTKFY's P/E ratio is 20.00. In terms of profitability, NVSEF's ROE is +0.31%, compared to PTKFY's ROE of +0.15%. Regarding short-term risk, NVSEF is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs PSYGF Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, PSYGF has a market cap of 1.1M. Regarding current trading prices, NVSEF is priced at $110.25, while PSYGF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas PSYGF's P/E ratio is -0.02. In terms of profitability, NVSEF's ROE is +0.31%, compared to PSYGF's ROE of +2.78%. Regarding short-term risk, NVSEF is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for NVSEF.
NVSEF vs CRXTQ Comparison
NVSEF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NVSEF stands at 209.2B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, NVSEF is priced at $110.25, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NVSEF currently has a P/E ratio of 17.28, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, NVSEF's ROE is +0.31%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, NVSEF is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for NVSEF.